United States · FDA National Drug Code directory
Ngenla
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-0505_7720dd2d-dc7e-4f9c-b7e5-7581d44ee9b5
- Product NDC
- 0069-0505
- Form
- INJECTION, SOLUTION
- Composition / generic term
- somatrogon-ghla
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230731
- Source listing expiry
- 20271231
Source-listed ingredients
- SOMATROGON — 24 mg/1.2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTRIDGE in 1 CARTON (0069-0505-02) / 1.2 mL in 1 CARTRIDGE (0069-0505-01) · 0069-0505-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →